playroulettegamefree| Fengyuan Pharmaceutical: Obtained 2 registration certificates for low-calcium peritoneal dialysis fluid drugs
Newsletter summary
[Fengyuan Pharmaceutical Co.PlayroulettegamefreeObtain the drug registration certificate of 2 kinds of low calcium peritoneal dialysate] Securities Times e company newsPlayroulettegamefreeFengyuan Pharmaceutical Co., Ltd. (000153) announced on the evening of May 10 that the company recently received a low calcium peritoneal dialysate (lactate-G2) approved and issued by the State Drug Administration.Playroulettegamefree.5%) Drug Registration CertificatePlayroulettegamefree...
Text of news flash
[Fengyuan Pharmaceutical: obtain two low-calcium Peritoneal Dialysate Drug Registration Certificate] Securities Times e, Fengyuan Pharmaceutical Co., Ltd. (000153) announced on the evening of May 10, recently, the company received the low-calcium peritoneal dialysate (lactate-G2.5%) drug registration certificate and the low-calcium peritoneal dialysate (lactate-G1.5%) drug registration certificate approved by the State Drug Administration. The above products are suitable for patients with acute and chronic renal failure who need continuous ambulatory peritoneal dialysis because non-dialysis treatment is ineffective. The above products belong to the regulations to be produced by the company's newly built annual output of 10 million bags of peritoneal dialysate, which is conducive to enriching the company's product line, optimizing product structure and further enhancing market competitiveness.
